← All stocks

Heartflow, Inc.

HTFL Net selling

CIK 0001464521 #1501 in the set updated 17 Sep 2026

Bought (120 mo)

$1.05M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$135.86M

$15.14M on a plan · $5.72M straight out of an exercise

Sold at will

$115.00M

5 of 33 sales

Net

−$134.81M

−$113.94M against sales at will

By person

11 insiders · 49 transactions

24.8×

John C.M. Farquhar holds 24.8 times base salary in stock. $16.10M of shares against $647.97K in salary for 2025.

Salary from the company's own proxy. The shares are what John C.M. Farquhar last reported holding, valued at $50.01, the price Common Stock. was last bought or sold at on the open market here, on 15 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Bain Capital Life Sciences Investors, LLC entity

10% owner

—

$115.00M (5)

−$115.00M

8,448,158

9.72%

$422.51M

—

Farquhar John C.M.

Chief Executive Officer

—

$10.94M (14) scheduled

−$10.94M

321,914

0.3702%

$16.10M

−13.8%

Rogers Campbell

Chief Medical Officer

—

$5.72M (6) scheduled

−$5.72M

86,459

0.0994%

$4.32M

—

Verghese Vikram

Chief Financial Officer

—

$3.75M (6) scheduled

−$3.75M

179,528

0.2065%

$8.98M

+56.4%

Lightcap Jeffrey C

Director

$1.05M (1)

—

+$1.05M

4,909,223

5.65%

$245.52M

—

Cullivan Julie A

Director

—

$446.61K (2) scheduled

−$446.61K

27,291

0.0314%

$1.36M

−38.6%

WELDON WILLIAM C

Director

—

243,931

0.2805%

$12.20M

+333.5%

BARABE TIMOTHY C

Director

—

188,231

0.2165%

$9.41M

+411.8%

Tansey Casey M

Director

—

114,750

0.1320%

$5.74M

—

Jones Marie L.

Chief Accounting Officer

—

32,176

0.0370%

$1.61M

—

HealthCor Partners Management LP entity

Director

—

0.0000%

$0.00

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Farquhar John C.M.

30 Jul 2026

Chief Executive Officer

Exercised, kept

9,737

$9.58

$93.28K

Farquhar John C.M.

30 Jul 2026

Chief Executive Officer

Exercised, kept

18,694

$2.22

$41.50K

Farquhar John C.M.

30 Jul 2026

Chief Executive Officer

Exercised, kept

2,789

$8.33

$23.23K

Verghese Vikram

27 Jul 2026

Chief Financial Officer

Exercised, kept

22,522

$2.22

$50.00K

Lightcap Jeffrey C

24 Jul 2026

Director

Exercised, kept

47,420

$19.00

$900.98K

BARABE TIMOTHY C

22 Jul 2026

Director

Exercised, kept

3,710

$19.00

$70.49K

Verghese Vikram

21 Jul 2026

Chief Financial Officer

Exercised, kept

22,522

$2.22

$50.00K

BARABE TIMOTHY C

17 Jul 2026

Director

Exercised, kept

5,000

$19.00

$95.00K

WELDON WILLIAM C

8 Jul 2026

Director

Exercised, kept

17,123

$8.33

$142.63K

WELDON WILLIAM C

8 Jul 2026

Director

Exercised, kept

17,123

$8.33

$142.63K

WELDON WILLIAM C

8 Jul 2026

Director

Exercised, kept

17,123

$8.33

$142.63K

Rogers Campbell

15 Jun 2026

Chief Medical Officer

Exercised, kept

10,000

$2.22

$22.20K

BARABE TIMOTHY C

11 Mar 2026

Director

Exercised, kept

8,667

$2.22

$19.24K

BARABE TIMOTHY C

17 Feb 2026

Director

Exercised, kept

2,497

$8.33

$20.80K

Bain Capital Life Sciences Investors, LLC

11 Aug 2025

10% owner

Exercised, kept indirect

433,924

$15.20

$6.60M

Show all 49 transactions →

What was left out

Form 4 filings counted 72

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 4

Sales on a Rule 10b5-1 plan 22

Sales straight out of an exercise 6

Sales at will 5

Transactions with no price 0

Shares from compensation/vesting 35,038,446

History held since 11 Aug 2025